ArticleScientific reports2022

The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer.

Fabio Quaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.